Alto Neuroscience, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -36.83M-61.13M
Share-based Compensation 2.89M7.63M
Gains from Investment Securities -0.53M5.25M
Cash from Operations -33.45M-47.42M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.28M0.34M
Depreciation & Amortization (CF) 0.40M0.50M
Change in Working Capital
Change in Account Payables -0.63M0.52M
Change in Accured Expenses -0.36M4.01M
Other Working Capital Changes -0.29M0.46M
Investing Activities
Capital Expenditures 0.47M2.08M
Cash from Investing Activities -0.47M-2.08M
Financing Activities
Other financing activities 1.39M4.62M
Cash from Financing Activities 68.13M135.69M
Additional items
Exchange Rate Effect -0.01M-0.01M
Change in Cash 34.20M86.18M
Free Cash Flow -33.92M-49.50M
Net Cash Flow 34.21M86.19M